Uric acid: a biomarker or risk factor for disease - the answer is here!
Friday, 25 September 2020, 08:30 - 09:30, Salzburg Hall
Chair: H.J. Lambers Heerspink, NL
D.I. Feig, US: Why is uric acid a potential target for complications?
N. Sandholm, FI: No it is only a marker
M. Mauer, US: Well let’s test it: allopurinol in type 1 diabetic kidney disease, the PERL study